[Second neoplasms in Hodgkin's disease]. 1983

A Tres Sánchez, and M A Fuertes Palacio, and C Poderós Baeta, and L Callén Sevilla, and R Cornudella Lacasa, and T Castiella Muruzábal, and M Gutiérrez Martín

UI MeSH Term Description Entries
D007680 Kidney Neoplasms Tumors or cancers of the KIDNEY. Cancer of Kidney,Kidney Cancer,Renal Cancer,Cancer of the Kidney,Neoplasms, Kidney,Renal Neoplasms,Cancer, Kidney,Cancer, Renal,Cancers, Kidney,Cancers, Renal,Kidney Cancers,Kidney Neoplasm,Neoplasm, Kidney,Neoplasm, Renal,Neoplasms, Renal,Renal Cancers,Renal Neoplasm
D008175 Lung Neoplasms Tumors or cancer of the LUNG. Cancer of Lung,Lung Cancer,Pulmonary Cancer,Pulmonary Neoplasms,Cancer of the Lung,Neoplasms, Lung,Neoplasms, Pulmonary,Cancer, Lung,Cancer, Pulmonary,Cancers, Lung,Cancers, Pulmonary,Lung Cancers,Lung Neoplasm,Neoplasm, Lung,Neoplasm, Pulmonary,Pulmonary Cancers,Pulmonary Neoplasm
D008297 Male Males
D009378 Neoplasms, Multiple Primary Two or more abnormal growths of tissue occurring simultaneously and presumed to be of separate origin. The neoplasms may be histologically the same or different, and may be found in the same or different sites. Neoplasms, Synchronous,Neoplasms, Synchronous Multiple Primary,Multiple Primary Neoplasms,Multiple Primary Neoplasms, Synchronous,Synchronous Multiple Primary Neoplasms,Synchronous Neoplasms,Multiple Primary Neoplasm,Neoplasm, Multiple Primary,Neoplasm, Synchronous,Primary Neoplasm, Multiple,Primary Neoplasms, Multiple,Synchronous Neoplasm
D002051 Burkitt Lymphoma A form of undifferentiated malignant LYMPHOMA usually found in central Africa, but also reported in other parts of the world. It is commonly manifested as a large osteolytic lesion in the jaw or as an abdominal mass. B-cell antigens are expressed on the immature cells that make up the tumor in virtually all cases of Burkitt lymphoma. The Epstein-Barr virus (HERPESVIRUS 4, HUMAN) has been isolated from Burkitt lymphoma cases in Africa and it is implicated as the causative agent in these cases; however, most non-African cases are EBV-negative. African Lymphoma,Burkitt Cell Leukemia,Burkitt Tumor,Lymphoma, Burkitt,Burkitt Leukemia,Burkitt's Leukemia,Burkitt's Lymphoma,Burkitt's Tumor,Leukemia, Lymphoblastic, Burkitt-Type,Leukemia, Lymphocytic, L3,Lymphocytic Leukemia, L3,Burkitts Leukemia,Burkitts Lymphoma,Burkitts Tumor,L3 Lymphocytic Leukemia,L3 Lymphocytic Leukemias,Leukemia, Burkitt,Leukemia, Burkitt Cell,Leukemia, Burkitt's,Leukemia, L3 Lymphocytic,Lymphoma, African,Lymphoma, Burkitt's,Tumor, Burkitt,Tumor, Burkitt's
D002283 Carcinoma, Bronchogenic Malignant neoplasm arising from the epithelium of the BRONCHI. It represents a large group of epithelial lung malignancies which can be divided into two clinical groups: SMALL CELL LUNG CANCER and NON-SMALL-CELL LUNG CARCINOMA. Carcinoma, Bronchial,Bronchial Carcinoma,Bronchial Carcinomas,Bronchogenic Carcinoma,Bronchogenic Carcinomas,Carcinomas, Bronchial,Carcinomas, Bronchogenic
D006689 Hodgkin Disease A malignant disease characterized by progressive enlargement of the lymph nodes, spleen, and general lymphoid tissue. In the classical variant, giant usually multinucleate Hodgkin's and REED-STERNBERG CELLS are present; in the nodular lymphocyte predominant variant, lymphocytic and histiocytic cells are seen. Granuloma, Hodgkin,Granuloma, Malignant,Hodgkin Lymphoma,Lymphogranuloma, Malignant,Granuloma, Hodgkin's,Granuloma, Hodgkins,Hodgkin Lymphoma, Adult,Hodgkin's Disease,Hodgkin's Lymphoma,Hodgkins Disease,Lymphocyte Depletion Hodgkin's Lymphoma,Lymphocyte-Rich Classical Hodgkin's Lymphoma,Mixed Cellularity Hodgkin's Lymphoma,Nodular Lymphocyte-Predominant Hodgkin's Lymphoma,Nodular Sclerosing Hodgkin's Lymphoma,Adult Hodgkin Lymphoma,Disease, Hodgkin,Disease, Hodgkin's,Disease, Hodgkins,Hodgkin Granuloma,Hodgkin's Granuloma,Hodgkins Granuloma,Hodgkins Lymphoma,Lymphocyte Rich Classical Hodgkin's Lymphoma,Lymphogranulomas, Malignant,Lymphoma, Hodgkin,Lymphoma, Hodgkin's,Malignant Granuloma,Malignant Granulomas,Malignant Lymphogranuloma,Malignant Lymphogranulomas,Nodular Lymphocyte Predominant Hodgkin's Lymphoma
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000230 Adenocarcinoma A malignant epithelial tumor with a glandular organization. Adenocarcinoma, Basal Cell,Adenocarcinoma, Granular Cell,Adenocarcinoma, Oxyphilic,Adenocarcinoma, Tubular,Adenoma, Malignant,Carcinoma, Cribriform,Carcinoma, Granular Cell,Carcinoma, Tubular,Adenocarcinomas,Adenocarcinomas, Basal Cell,Adenocarcinomas, Granular Cell,Adenocarcinomas, Oxyphilic,Adenocarcinomas, Tubular,Adenomas, Malignant,Basal Cell Adenocarcinoma,Basal Cell Adenocarcinomas,Carcinomas, Cribriform,Carcinomas, Granular Cell,Carcinomas, Tubular,Cribriform Carcinoma,Cribriform Carcinomas,Granular Cell Adenocarcinoma,Granular Cell Adenocarcinomas,Granular Cell Carcinoma,Granular Cell Carcinomas,Malignant Adenoma,Malignant Adenomas,Oxyphilic Adenocarcinoma,Oxyphilic Adenocarcinomas,Tubular Adenocarcinoma,Tubular Adenocarcinomas,Tubular Carcinoma,Tubular Carcinomas
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

A Tres Sánchez, and M A Fuertes Palacio, and C Poderós Baeta, and L Callén Sevilla, and R Cornudella Lacasa, and T Castiella Muruzábal, and M Gutiérrez Martín
March 1989, Revista clinica espanola,
A Tres Sánchez, and M A Fuertes Palacio, and C Poderós Baeta, and L Callén Sevilla, and R Cornudella Lacasa, and T Castiella Muruzábal, and M Gutiérrez Martín
January 1979, Cancer chemotherapy and pharmacology,
A Tres Sánchez, and M A Fuertes Palacio, and C Poderós Baeta, and L Callén Sevilla, and R Cornudella Lacasa, and T Castiella Muruzábal, and M Gutiérrez Martín
June 1989, Hematology/oncology clinics of North America,
A Tres Sánchez, and M A Fuertes Palacio, and C Poderós Baeta, and L Callén Sevilla, and R Cornudella Lacasa, and T Castiella Muruzábal, and M Gutiérrez Martín
September 1993, Current opinion in oncology,
A Tres Sánchez, and M A Fuertes Palacio, and C Poderós Baeta, and L Callén Sevilla, and R Cornudella Lacasa, and T Castiella Muruzábal, and M Gutiérrez Martín
August 1994, Australian and New Zealand journal of medicine,
A Tres Sánchez, and M A Fuertes Palacio, and C Poderós Baeta, and L Callén Sevilla, and R Cornudella Lacasa, and T Castiella Muruzábal, and M Gutiérrez Martín
March 1996, The New England journal of medicine,
A Tres Sánchez, and M A Fuertes Palacio, and C Poderós Baeta, and L Callén Sevilla, and R Cornudella Lacasa, and T Castiella Muruzábal, and M Gutiérrez Martín
March 1983, Archives of internal medicine,
A Tres Sánchez, and M A Fuertes Palacio, and C Poderós Baeta, and L Callén Sevilla, and R Cornudella Lacasa, and T Castiella Muruzábal, and M Gutiérrez Martín
March 1982, Blood,
A Tres Sánchez, and M A Fuertes Palacio, and C Poderós Baeta, and L Callén Sevilla, and R Cornudella Lacasa, and T Castiella Muruzábal, and M Gutiérrez Martín
July 1984, Journal of clinical oncology : official journal of the American Society of Clinical Oncology,
A Tres Sánchez, and M A Fuertes Palacio, and C Poderós Baeta, and L Callén Sevilla, and R Cornudella Lacasa, and T Castiella Muruzábal, and M Gutiérrez Martín
April 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology,
Copied contents to your clipboard!